Novel small molecule cyclin-dependent kinases modulators in human clinical trials.

Cancer biology & therapy

Volumn 2, Issue 4 Suppl 1, 2003, Pages

  Senderowicz, Adrian M ^a  

^a NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; ANTINEOPLASTIC AGENT; CYCLIN DEPENDENT KINASE; ENZYME INHIBITOR; RETINOBLASTOMA PROTEIN;

BINDING SITE; BIOLOGICAL MODEL; CELL CYCLE; CELL DIVISION; CHEMICAL MODEL; CHEMISTRY; CLINICAL TRIAL; DRUG ANTAGONISM; DRUG EFFECT; ENZYMOLOGY; HUMAN; METABOLISM; NEOPLASM; REVIEW;

ADENOSINE TRIPHOSPHATE; ANTINEOPLASTIC AGENTS; BINDING SITES; CELL CYCLE; CELL DIVISION; CLINICAL TRIALS; CYCLIN-DEPENDENT KINASES; ENZYME INHIBITORS; HUMANS; MODELS, BIOLOGICAL; MODELS, CHEMICAL; NEOPLASMS; RETINOBLASTOMA PROTEIN;

MLCS; MLOWN;

EID: 1342335029     PISSN: 15384047     EISSN: None     Source Type: Journal    
DOI: 10.4161/cbt.207     Document Type: Review

References (204)